Inactief instrument

Andere talen Amryt Pharma plc London S.E.

Aandelen

GB00BKB1MS30_GB

GB00BKLTQ412

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Chiesi Global Rare Diseases Announces Health Canada Approval of MYALEPTA™ (metreleptin for injection) for the Treatment of Patients with Lipodystrophy	05/02
Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg Pharma	10/11
Amryt Pharma plc(NasdaqGS:AMYT) dropped from S&P Global BMI Index	13-04-23
2022 for Chiesi, The Group's international growth continues	12-04-23
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc	12-04-23
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc	12-04-23
Amryt Pharma plc(NasdaqGS:AMYT) dropped from NASDAQ Composite Index	12-04-23
Chiesi Farmaceutici S.p.A. completed the acquisition of Amryt Pharma plc from Athyrium Capital Management, LP, Highbridge Capital Management, LLC, Joe Wiley, Rory Nealon, Ray Stafford and others.	12-04-23
2022 for Chiesi: The Group’s international growth continues	11-04-23
Amryt Pharma Plc - High Court of Justice of England and Wales Sanctions Scheme of Arrangement	04-04-23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement	03-04-23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement	03-04-23
Amryt Pharma's Shareholders Approve Acquisition by Chiesi Farmaceutici	22-03-23
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici	22-03-23
Amryt Pharma plc’s Equity Buyback announced on March 9, 2022, has expired.	08-03-23
AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT	24-02-23
AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023	16-02-23
AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023	16-02-23
AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT	11-01-23
Sector Update: Health Care Stocks Largely Struggle Monday	09-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Amryt Pharma plc London S.E.

Aandelen

GB00BKB1MS30_GB

GB00BKLTQ412

Andere talen

Filters